Pricing Analysis of a New Drug
A biopharma industry leader with potential candidates in a phase III trial for neurological and cardiovascular diseases was interested in making a pricing decision. The engagement included understanding competitor drug positioning along with efficacy study analysis to provide better insights on price points for clients. Client Background: The client is one of the key players […]
Antidiabetic Drugs: Implications of Price Control Regulations
The global costs of diabetes are estimated to reach $2 trillion by 2030. This is due to the increasing number of type 2 diabetes patients and high drug prices. To reduce the global economic burden, expenditure, and effect of this disease, several policies are being developed in terms of health and social security systems. To devise policy […]